Sunrise Health Medical Associates（Oakland, CA）

Sunrise Health Medical Associates has served Oakland, CA since 2006, providing physician-supervised medical weight loss programs under the direction of Dr. J.S. Basi, MD. With training from an Internal Medicine Residency at the University of Medicine and Dentistry of New Jersey, Dr. Basi brings nearly two decades of clinical experience to metabolic health management in the East Bay community. The practice focuses exclusively on evidence-based weight loss interventions, with particular expertise in GLP-1 receptor agonist therapies that address the hormonal and metabolic factors underlying obesity and weight regain.

The clinic’s medical weight loss protocols center on two FDA-approved GLP-1 medications: semaglutide and tirzepatide. Semaglutide works by mimicking the glucagon-like peptide-1 hormone to reduce appetite, slow gastric emptying, and improve glycemic control in patients with or without type 2 diabetes. Tirzepatide represents a dual-action approach, activating both GLP-1 and GIP receptors to enhance insulin secretion and suppress appetite through complementary pathways. Dr. Basi prescribes these medications as part of comprehensive programs that include baseline metabolic assessments, body composition analysis, and ongoing monitoring of cardiovascular and metabolic markers. Patients receive individualized dosing schedules based on their response, tolerance, and weight loss goals, with adjustments made during regular follow-up appointments.

Dr. Basi’s approach to weight management integrates pharmacotherapy with practical lifestyle modification strategies tailored to each patient’s medical history, comorbidities, and daily routines. Initial consultations include a thorough review of previous weight loss attempts, current medications, thyroid function, and screening for contraindications to GLP-1 therapy such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The practice addresses common barriers to weight loss including insulin resistance, hormonal imbalances, and appetite dysregulation that often undermine conventional diet-and-exercise approaches. Patients with obesity-related conditions such as hypertension, dyslipidemia, fatty liver disease, or prediabetes receive coordinated care that targets both weight reduction and metabolic risk factors.

Sunrise Health Medical Associates requires in-person consultations at their Oakland location, allowing Dr. Basi to conduct physical examinations, review laboratory results face-to-face, and establish the physician-patient relationship necessary for controlled substance prescribing and ongoing medication management. Follow-up visits typically occur every four to six weeks during the initial titration phase, then monthly or quarterly once patients reach maintenance dosing. The practice provides education on managing common side effects of GLP-1 medications including nausea, constipation, and reduced appetite, along with nutritional guidance to ensure adequate protein intake and micronutrient status during periods of caloric restriction. Patients have direct access to Dr. Basi’s clinical team for questions about medication administration, side effect management, or concerns between scheduled appointments.

With eighteen years of practice in Oakland, Sunrise Health Medical Associates has established relationships with local laboratories, imaging centers, and specialty providers to facilitate comprehensive metabolic care. The clinic accepts most major insurance plans for office visits and metabolic testing, though patients should verify coverage for GLP-1 medications, which may require prior authorization or step therapy documentation. Dr. Basi’s internal medicine background enables management of complex patients with multiple comorbidities who require careful medication reconciliation and monitoring. The practice’s longevity in the Oakland community and focus on physician-supervised protocols distinguish it from retail weight loss programs, providing patients with medical oversight grounded in nearly two decades of clinical experience in metabolic health management.